Table of Contents
Zepbound and Mounjaro
Zepbound and Mounjaro are two names for the same medication, both containing tirzepatide as the active ingredient. People often gets confused and ask “Zepbound vs Mounjaro”. Mounjaro is approved for use along with diet and exercise to improve blood sugar in adults with type 2 diabetes mellitus. Zepbound, the new name for the same medication, has FDA approval for chronic weight management in adults with obesity or those characterized as overweight with at least one weight-related health condition, such as high blood pressure or heart disease.
Clinical trials have demonstrated that Zepbound can result in more than 20% average weight loss on higher doses over 72 weeks, showing stronger efficacy compared to other approved medicines.
Side Effects and Warnings:
The main side effects of Zepbound include gastrointestinal issues such as nausea, vomiting, constipation, and diarrhea. The drug’s label will also carry warnings for:
- Inflammation of the pancreas
- Gallbladder problems
- Low blood sugar
- Acute kidney injury
- Diabetic retinopathy or damage to the eye’s retina in patients with type 2 diabetes mellitus
- Suicidal behavior or thinking
It’s important to note that these warnings are crucial considerations for individuals using Zepbound, and consultation with healthcare professionals is advised.
Zepbound or Mounjaro stock Price
Eli Lilly’s stock (LLY) rose more than 3% on November 9, 2023, after the FDA approved Zepbound. The approval of Zepbound is a watershed moment for Lilly and a society grappling with the high costs of caring for patients with obesity
Zepbound or Mounjaro weight loss cost
The list price of Zepbound is approximately $1,060 for a month’s supply. However, Eli Lilly has implemented a commercial savings card program to enhance access for individuals considering Zepbound. People who are commercially insured with coverage for Zepbound may be eligible to pay as low as $25 for a 1-month or 3-month prescription, while those who are commercially insured without coverage for Zepbound may be eligible to pay as low as $550 for a 1-month prescription of Zepbound, which is approximately 50% lower than the list price.